These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 7561233)
1. Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer. Safi F; Kuhns V; Beger HG Int J Biol Markers; 1995; 10(2):100-6. PubMed ID: 7561233 [TBL] [Abstract][Full Text] [Related]
2. CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma. Pectasides D; Mylonakis A; Kostopoulou M; Papadopoulou M; Triantafillis D; Varthalitis J; Dimitriades M; Athanassiou A Am J Clin Oncol; 1997 Aug; 20(4):348-53. PubMed ID: 9256887 [TBL] [Abstract][Full Text] [Related]
3. The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen. Safi F; Kohler I; Röttinger E; Beger H Cancer; 1991 Aug; 68(3):574-82. PubMed ID: 2065278 [TBL] [Abstract][Full Text] [Related]
4. Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. Marrelli D; Pinto E; De Stefano A; Farnetani M; Garosi L; Roviello F Am J Surg; 2001 Jan; 181(1):16-9. PubMed ID: 11248169 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma. Gaspar MJ; Arribas I; Coca MC; Díez-Alonso M Tumour Biol; 2001; 22(5):318-22. PubMed ID: 11553862 [TBL] [Abstract][Full Text] [Related]
7. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer. Yin LK; Sun XQ; Mou DZ Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer. Gong X; Zhang H J Clin Lab Anal; 2020 Jul; 34(7):e23268. PubMed ID: 32118318 [TBL] [Abstract][Full Text] [Related]
9. Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer. Tian SB; Yu JC; Kang WM; Ma ZQ; Ye X; Cao ZJ; Yan C Asian Pac J Cancer Prev; 2014; 15(15):6295-300. PubMed ID: 25124614 [TBL] [Abstract][Full Text] [Related]
10. Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer. Mattar R; Alves de Andrade CR; DiFavero GM; Gama-Rodrigues JJ; Laudanna AA Rev Hosp Clin Fac Med Sao Paulo; 2002; 57(3):89-92. PubMed ID: 12118264 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Serum CA72-4 and CEA Levels in Patient with Endoscopically Suspected Gastric Carcinoma. Rehena Z; Ghosh CK; Afroz F; Alam MB; Ferdousi S; Mahmuduzzaman M; Sultana T; Ahmed AN Mymensingh Med J; 2015 Jul; 24(3):542-9. PubMed ID: 26329953 [TBL] [Abstract][Full Text] [Related]
12. Comparison of CA 15-3 and CEA in diagnosis and monitoring of breast cancer. Safi F; Kohler I; Röttinger E; Suhr P; Beger HG Int J Biol Markers; 1989; 4(4):207-14. PubMed ID: 2628501 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma. Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559 [TBL] [Abstract][Full Text] [Related]
14. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459 [TBL] [Abstract][Full Text] [Related]
15. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Lai IR; Lee WJ; Huang MT; Lin HH Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226 [TBL] [Abstract][Full Text] [Related]
16. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer. Kim JH; Jun KH; Jung H; Park IS; Chin HM Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088 [TBL] [Abstract][Full Text] [Related]
18. The characteristics of the serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer cases. Wada N; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y Surg Today; 2017 Feb; 47(2):227-232. PubMed ID: 27566604 [TBL] [Abstract][Full Text] [Related]
19. TAG-72, CA 19.9 and CEA as tumor markers in gastric cancer. Filella X; Fuster J; Molina R; Grau JJ; García-Valdecasas JC; Grande L; Estapé J; Ballesta AM Acta Oncol; 1994; 33(7):747-51. PubMed ID: 7993641 [TBL] [Abstract][Full Text] [Related]
20. Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19-9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma. Qiu MZ; Lin JZ; Wang ZQ; Wang FH; Pan ZZ; Luo HY; Li YH; Zhou ZW; He YJ; Xu RH Int J Biol Markers; 2009; 24(4):258-64. PubMed ID: 20082274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]